SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950144-07-009653
Filing Date
2007-10-29
Accepted
2007-10-29 17:04:18
Documents
5
Period of Report
2007-08-14
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 NOVEN PHARMACEUTICALS, INC. g10057e8vkza.htm 8-K/A 16453
2 EX-23.1 CONSENT OF BDO SEIDMAN, LLP g10057exv23w1.htm EX-23.1 1661
3 EX-99.1 AUDITED FINANCIAL STATEMENTS OF JDS PHARMACEUTICALS g10057exv99w1.htm EX-99.1 156747
4 EX-99.2 UNAUDITED FINANCIAL STATEMENTS OF JDS PHARMACEUTICALS g10057exv99w2.htm EX-99.2 81341
5 EX-99.3 UNAUDITED PRO FORMA FINANCIAL INFORMATION g10057exv99w3.htm EX-99.3 182470
  Complete submission text file 0000950144-07-009653.txt   440106
Mailing Address 11960 SW 144TH STREET MIAMI FL 33185
Business Address 11960 SW 144TH ST MIAMI FL 33186 3052535099
NOVEN PHARMACEUTICALS INC (Filer) CIK: 0000815838 (see all company filings)

IRS No.: 592767632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-17254 | Film No.: 071197080
SIC: 2834 Pharmaceutical Preparations